Delzell E, Sathiakumar N, Hovinga M, Macaluso M, Julian J, Larson R, Cole P, Muir D C
Department of Epidemiology, School of Public Health, University of Alabama at Birmingham 35294, USA.
Toxicology. 1996 Oct 28;113(1-3):182-9. doi: 10.1016/0300-483x(96)03443-9.
Although 1,3-butadiene (BD) has been classified as an animal carcinogen, epidemiologic research has reported inconsistent results on the relationship between BD and lymphopoietic and other cancers in humans. This study evaluated the mortality experience of 15649 men employed for at least 1 year at any of eight North American styrene-butadiene rubber (SBR) plants. About 75% of the subjects were exposed to BD; 83% were exposed to styrene (STY). During 1943-1991, the cohort had a total of 386172 and an average of 25 person-years of follow-up, with 3976 deaths observed compared to 4553 deaths expected based on general population mortality rates (standardized mortality ratio (SMR) = 87, 95% confidence interval (CI) = 85-90). More than expected leukemia deaths occurred in the overall cohort (48 observed/37 expected, SMR = 131, CI = 97-174) and among ever hourly subjects (45/32, SMR = 143, CI = 104-191). The excess was concentrated among ever hourly subjects with 10+ years worked and 20+ years since hire (28/13, SMR = 224, CI = 149-323) and among subjects in polymerization (15/6.0, SMR = 251, CI = 140-414), maintenance labor (13/4.9, SMR = 265, CI = 141-453) and laboratories (10/2.3, SMR = 431, CI = 207-793), three areas with potential for relatively high exposure to BD or STY monomers. Some cohort sub-groups had slight increases in deaths from lymphopoietic cancers other than leukemia, but mortality patterns by race, years worked and process group within the SBR industry did not indicate a causal association with occupational exposures. These results indicate that exposures in the SBR industry cause leukemia.
虽然1,3 - 丁二烯(BD)已被列为动物致癌物,但流行病学研究报告的关于BD与人类淋巴造血及其他癌症之间关系的结果并不一致。本研究评估了在北美八家丁苯橡胶(SBR)工厂中任何一家工作至少1年的15649名男性的死亡情况。约75%的受试者接触过BD;83%接触过苯乙烯(STY)。在1943年至1991年期间,该队列共有386172人年,平均随访25人年,观察到3976例死亡,而根据一般人群死亡率预期为4553例死亡(标准化死亡比(SMR)= 87,95%置信区间(CI)= 85 - 90)。整个队列中白血病死亡人数超过预期(观察到48例/预期37例,SMR = 131,CI = 97 - 174),在曾经按小时计酬的受试者中也是如此(45/32,SMR = 143,CI = 104 - 191)。超额情况集中在工作10年以上且入职20年以上的曾经按小时计酬的受试者中(28/(13,SMR = 224,CI = 149 - 323)以及聚合部门的受试者中(15/6.0,SMR = 251,CI = 140 - 414)、维修工人中(13/4.9,SMR = 265,CI = 141 - 453)和实验室人员中(10/2.3,SMR = 431,CI = 207 - 793),这三个领域有相对较高接触BD或STY单体的可能性。该队列的一些亚组中,除白血病外的淋巴造血系统癌症死亡人数略有增加,但SBR行业内按种族、工作年限和工艺组划分的死亡模式并未表明与职业暴露存在因果关系。这些结果表明,SBR行业的暴露会导致白血病。